BioCentury
ARTICLE | Clinical News

Dymista azelastine/fluticasone regulatory update

June 10, 2013 7:00 AM UTC

Meda said the Swedish Dental and Pharmaceutical Benefits Agency will reimburse Dymista azelastine/fluticasone to treat seasonal and perennial allergic rhinitis. The product was approved under the EU's...